Bio-Rad Laboratories BIO Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Net Sales by Business | |||||
| All Other Segments | $0-100% | $500K-85.7% | $3.5M-12.5% | $4M— | |
| Clinical Diagnostics | $1.56B+1.6% | $1.54B+3.3% | $1.49B+2.6% | $1.45B-4.3% | |
| Life Science | $1.02B-0.7% | $1.03B-12.8% | $1.18B-12.5% | $1.35B-3.8% | |
| Net Sales by Geography | |||||
| Americas | $165.4M-2.3% | $169.3M+1.8% | $166.3M+7.1% | $155.3M-0.7% | |
| Asia Pacific | $513.3M-1.6% | $521.7M-7.1% | $561.8M-12.2% | $639.5M-7.1% | |
| Europe | $881.8M+5.7% | $834.1M+1.7% | $819.8M-3.8% | $851.9M-10.0% | |
| UNITED STATES | $1.02B-1.8% | $1.04B-7.3% | $1.12B-2.8% | $1.16B+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Rad Laboratories break its business down?
- Bio-Rad Laboratories (BIO) reports net sales by business across 3 parts — All Other Segments, Clinical Diagnostics and Life Science. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Rad Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Rad Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
